Roberto Barriales‐Villa

2023 ESC Guidelines for the management of cardiomyopathies

Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno et al. · European Heart Journal · 2023 · 2K citations · Full text

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

Martín Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro et al. · Journal of the American College of Cardiology · 2016 · 458 citations · Full text

Cardiomyopathy, Heart Failure, Genetics +8

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

Gabrielle Norrish, Tao Ding, Ella Field et al. · JAMA Cardiology · 2019 · 232 citations · Full text

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Michael E. Nassif et al. · New England Journal of Medicine · 2024 · 230 citations · Full text